141 related articles for article (PubMed ID: 37565277)
1. Buds, clusters, and transitions in 21st century colorectal carcinoma: revolution or reinvention?
Feakins RM; Loughrey MB; Silver A
J Pathol; 2023 Oct; 261(2):121-124. PubMed ID: 37565277
[TBL] [Abstract][Full Text] [Related]
2. Tumour budding and poorly differentiated clusters in colon cancer - different manifestations of partial epithelial-mesenchymal transition.
Pavlič A; Boštjančič E; Kavalar R; Ilijevec B; Bonin S; Zanconati F; Zidar N
J Pathol; 2022 Nov; 258(3):278-288. PubMed ID: 36062412
[TBL] [Abstract][Full Text] [Related]
3. Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor Buds.
Hong M; Kim JW; Shin MK; Kim BC
J Korean Med Sci; 2017 Oct; 32(10):1595-1602. PubMed ID: 28875602
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.
McCorry AM; Loughrey MB; Longley DB; Lawler M; Dunne PD
J Pathol; 2018 Dec; 246(4):422-426. PubMed ID: 30105762
[TBL] [Abstract][Full Text] [Related]
5. Pseudobudding: ruptured glands do not represent true tumor buds.
Haddad TS; van den Dobbelsteen L; Öztürk SK; Geene R; Nijman IJ; Verrijp K; Jamieson NB; Wood C; van Vliet S; Reuvers L; Achouiti S; Rutgers N; Brouwer N; Simmer F; Zlobec I; Lugli A; Nagtegaal ID
J Pathol; 2023 Sep; 261(1):19-27. PubMed ID: 37403270
[TBL] [Abstract][Full Text] [Related]
6. Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters.
Pai RK; Hartman D; Schaeffer DF; Rosty C; Shivji S; Kirsch R; Pai RK
Histopathology; 2021 Sep; 79(3):391-405. PubMed ID: 33590485
[TBL] [Abstract][Full Text] [Related]
7. A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction.
Pastorino GA; Sheraj I; Huebner K; Ferrero G; Kunze P; Hartmann A; Hampel C; Husnugil HH; Maiuthed A; Gebhart F; Schlattmann F; Gulec Taskiran AE; Oral G; Palmisano R; Pardini B; Naccarati A; Erlenbach-Wuensch K; Banerjee S; Schneider-Stock R
J Pathol; 2024 Mar; 262(3):347-361. PubMed ID: 38235615
[TBL] [Abstract][Full Text] [Related]
8. Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition.
Maffeis V; Cappellesso R; Galuppini F; Guzzardo V; Zanon A; Cazzador D; Emanuelli E; Ventura L; Martini A; Fassina A
Virchows Arch; 2020 Aug; 477(2):241-248. PubMed ID: 31980958
[TBL] [Abstract][Full Text] [Related]
9. Membranous S100A10 involvement in the tumor budding of colorectal cancer during oncogenesis: report of two cases with immunohistochemical analysis.
Arai K; Ishimatsu H; Iwasaki T; Tsuchiya C; Sonoda A; Ohata K
World J Surg Oncol; 2020 Nov; 18(1):289. PubMed ID: 33160379
[TBL] [Abstract][Full Text] [Related]
10. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
[TBL] [Abstract][Full Text] [Related]
11. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
McCart Reed AE; Kutasovic JR; Vargas AC; Jayanthan J; Al-Murrani A; Reid LE; Chambers R; Da Silva L; Melville L; Evans E; Porter A; Papadimos D; Thompson EW; Lakhani SR; Simpson PT
J Pathol; 2016 Mar; 238(4):489-94. PubMed ID: 26510554
[TBL] [Abstract][Full Text] [Related]
12. Tumour budding in colorectal carcinoma.
Prall F
Histopathology; 2007 Jan; 50(1):151-62. PubMed ID: 17204028
[TBL] [Abstract][Full Text] [Related]
13. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
Zlobec I; Lugli A
Oncotarget; 2010 Nov; 1(7):651-61. PubMed ID: 21317460
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil extracellular traps drive epithelial-mesenchymal transition of human colon cancer.
Stehr AM; Wang G; Demmler R; Stemmler MP; Krug J; Tripal P; Schmid B; Geppert CI; Hartmann A; Muñoz LE; Schoen J; Völkl S; Merkel S; Becker C; Schett G; Grützmann R; Naschberger E; Herrmann M; Stürzl M
J Pathol; 2022 Apr; 256(4):455-467. PubMed ID: 34939675
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtypes of invasive breast carcinoma of no special type, their correlation with histopathological features, Ki 67 index and tumor budding: A retrospective comparative study.
Radhakrishnan N; Mathews A; Rajeev KR; Nair PS; Bhargavan R; Viswanathan AJ
Indian J Pathol Microbiol; 2022; 65(4):772-780. PubMed ID: 36308179
[TBL] [Abstract][Full Text] [Related]
16. Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy.
Bhangu A; Wood G; Mirnezami A; Darzi A; Tekkis P; Goldin R
Surg Oncol; 2012 Dec; 21(4):316-23. PubMed ID: 22981546
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer.
Brouwer NP; Webbink L; Haddad TS; Rutgers N; van Vliet S; Wood CS; Jansen PW; Lafarge MW; ; de Wilt JH; Hugen N; Simmer F; Jamieson NB; Tauriello DV; Kölzer VH; Vermeulen M; Nagtegaal ID
J Pathol; 2023 Dec; 261(4):401-412. PubMed ID: 37792663
[TBL] [Abstract][Full Text] [Related]
18. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated clusters with larger extents have a greater impact on survival: a semi-quantitative pathological evaluation for 239 patients with non-mucinous pT2-3 colorectal carcinoma.
Kinoshita O; Kishimoto M; Murayama Y; Yasukawa S; Konishi E; Otsuji E; Yanagisawa A
World J Surg Oncol; 2015 Apr; 13():140. PubMed ID: 25879220
[TBL] [Abstract][Full Text] [Related]
20. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
